Бельгия - немецкий - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

reckitt benckiser (belgium) - amorolfine hydrochloride - wirkstoffhaltiger nagellack - 50 mg/ml - amorolfine hydrochloride 55.74 mg/ml - amorolfine

Бельгия - немецкий - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sol - lachgas - gas zur medizinischen anwendung, verflüssigt - 100% v/v - lachgas - nitrous oxide

Бельгия - немецкий - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eurocept international - lidocain; tetracaine - wirkstoffhaltiges pflaster - 70 mg - 70 mg - lidocain 70 mg; tetracaine 70 mg - lidocaine, combinations

Европейский союз - немецкий - EMA (European Medicines Agency)

janssen-cilag international nv - esketamine hydrochloride - depressive störung - andere antidepressiva - spravato, in kombination mit einem ssri oder snri, ist indiziert für erwachsene patienten mit therapieresistenten depressiven patienten, die nicht geantwortet haben, um mindestens zwei verschiedene behandlungen mit antidepressiva in der aktuellen moderaten bis schweren depressiven episode.

Европейский союз - немецкий - EMA (European Medicines Agency)

janssen-cilag international n.v.    - recombinant adenovirus type 26 (ad26) encoding the glycoprotein (gp) of the ebola virus zaire (zebov) mayinga strain - hämorrhagische fieber, ebola - - impfstoffe - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.

Европейский союз - немецкий - EMA (European Medicines Agency)

janssen-cilag international n.v.    - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - hämorrhagische fieber, ebola - - impfstoffe - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.

Европейский союз - немецкий - EMA (European Medicines Agency)

vertex pharmaceuticals (ireland) limited - ivacaftor, tezacaftor, elexacaftor - mukoviszidose - andere produkte für die atemwege - kaftrio is indicated in a combination regimen with ivacaftor for the treatment of cystic fibrosis (cf) in patients aged 6 years and older who have at least one f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene.

Европейский союз - немецкий - EMA (European Medicines Agency)

janssen-cilag international nv - rilpivirine - hiv-infektionen - antivirale mittel zur systemischen anwendung - rekambys is indicated, in combination with cabotegravir injection, for the treatment of human immunodeficiency virus type 1 (hiv 1) infection in adults who are virologically suppressed (hiv-1 rna < 50 copies/ml) on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with, agents of the nnrti and ini class.

Европейский союз - немецкий - EMA (European Medicines Agency)

janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - impfstoffe - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older. der einsatz dieses impfstoffs sollte in übereinstimmung mit den offiziellen empfehlungen.

Европейский союз - немецкий - EMA (European Medicines Agency)

janssen-cilag international n.v.    - amivantamab - karzinom, nicht kleinzellige lunge - antineoplastische mittel - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.